Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation
Clinical trial NCT02511041 · TERMINATED
Trial details
- NCT number
- NCT02511041
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-30
- Primary completion
- 2017-01-24
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.